Lumos Pharma Inc (NASDAQ:LUMO) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Lota S Zoth Other companies: First Financial Bankshares, Inc. (Director · Since at least Apr 28, 2026); enGene Therapeutics Inc. (Director · Since at least Dec 18, 2023); 89bio Inc (Director · Since at least Jun 1, 2020); Inovio Pharmaceuticals, Inc. (Director · Since at least Jan 3, 2019); Zymeworks Inc. (Director · Jan 1, 2019 – Dec 21, 2022 · Past); Spark Therapeutics Inc (CHIEF SCIENTIFIC OFFICER, Director · Jan 6, 2016 – Dec 17, 2019 · Past); Hyperion Therapeutics Inc (Director · Jul 25, 2012 – May 7, 2015 · Past); Orexigen Therapeutics Inc (Director · Apr 26, 2012 – Jul 14, 2017 · Past); Medimmune Inc (SVP, Chief Financial Officer · Feb 23, 2006 – Jun 18, 2007 · Past) | Director · Nov 2, 2012 – Dec 12, 2024 · Past |
| Paolo Pucci Other companies: Replimune Group, Inc. (Director · Since at least Apr 1, 2020); West Pharmaceutical Services, Inc. (Director · Since at least Sep 12, 2016); Trillium Therapeutics Inc (Director · Jan 1, 2021 – Nov 17, 2021 · Past); Dyax Corp (Director · Nov 1, 2011 – Jan 13, 2016 · Past); ArQule Inc (Chief Executive Officer, Director · Jun 9, 2008 – Jan 16, 2020 · Past) | Director · Nov 12, 2015 – May 23, 2018 · Past |
| Emmett Cunningham Other companies: NovaBridge Biosciences (Director · Since at least Mar 18, 2026); Annexon, Inc. (Director · Jul 23, 2020 – Jul 23, 2020 · Past); Galera Therapeutics, Inc. (Director · Nov 6, 2019 – Jun 14, 2023 · Past); Venus Concept Inc (Director · Oct 11, 2017 – Oct 11, 2017 · Past) | Director · Mar 18, 2020 – Apr 3, 2020 · Past |
| Richard J. Hawkins Other companies: Plus Therapeutics, Inc. (Director · Since at least Jun 25, 2020); Savara, Inc. (Audit Committee · Since at least Dec 17, 2017); SciClone Pharmaceuticals Inc (Director · Oct 13, 2017 – Oct 13, 2017 · Past) | Chief Executive Officer, Director · Mar 18, 2020 – Dec 12, 2024 · Past |
| Joseph Saluri Other companies: Cibus, Inc. (General Counsel, EVP-Corp Dev · Jul 20, 2017 – Jul 20, 2017 · Past); Zevra Therapeutics, Inc. (Director · Apr 15, 2015 – Apr 25, 2023 · Past) | Director · Nov 10, 2011 – May 12, 2017 · Past |
| Aaron Schuchart Other companies: Spyre Therapeutics, Inc. (Chief Business Officer · May 22, 2017 – Feb 28, 2019 · Past) | Chief Business Officer · May 19, 2021 – Dec 12, 2024 · Past |
| Eugene P Kennedy Other companies: Galera Therapeutics, Inc. (Chief Medical Officer · Sep 1, 2022 – Feb 25, 2023 · Past) | Chief Medical Officer · Nov 13, 2017 – Feb 1, 2021 · Past |
| Kevin M Lalande Other companies: Molecular Templates Inc (Director · Jun 3, 2022 – Sep 27, 2024 · Past) | Director · May 5, 2022 – Dec 12, 2024 · Past |
| Bradley J Powers | General Counsel · Aug 3, 2019 – Dec 12, 2024 · Past |
| Brian Wiley | Chief Commercial Officer · Jan 2, 2013 – Mar 9, 2018 · Past |
| Carl W Langren | Chief Financial Officer · Nov 7, 2013 – Apr 1, 2021 · Past |
| Chad Allen Johnson | Director · Mar 19, 2018 – Dec 12, 2024 · Past |
| David J Lundquist | Director · Nov 10, 2011 – Mar 5, 2012 · Past |
| John C McKew | Chief Scientific Officer · Mar 18, 2020 – Dec 12, 2024 · Past |
| Lori D Lawley | Chief Financial Officer · Aug 1, 2018 – Dec 12, 2024 · Past |
| Nicholas N Vahanian | President · Nov 10, 2011 – Jul 31, 2019 · Past |
| Pisit Duke Pitukcheewanont | Chief Medical Officer · Jan 4, 2024 – Dec 12, 2024 · Past |
| Sarah Alexander | Director · Nov 10, 2011 – Nov 16, 2011 · Past |
| William J Ramsey | Quality Assurance Officer · Nov 10, 2011 – Jun 1, 2015 · Past |